Abstract
Disturbances of cognitive functions, e.g. several types of memory, executive function, attention, verbal fluency, are characteristic of mood disorders and schizophrenia. Imaging techniques in several modalities are likely to provide an objective biomarker for cognitive impairment in these psychiatric illnesses. This issue was discussed interactively in this symposium, based on cutting - edge evidence from near - infrared spectroscopy (presented by Dr. Kazuyuki Nakagome) , functional magnetic resonance imaging (Drs. Steven G. Potkin and Bernardo DellʼOsso) , and positron emission tomography (Dr. Paolo Brambilla) .
